Sankar N. Maity - Publications

The University of Texas School of Public Health 
Molecular Biology, Cell Biology

15/34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Maity SN, Titus MA, Gyftaki R, Wu G, Lu JF, Ramachandran S, Li-Ning-Tapia EM, Logothetis CJ, Araujo JC, Efstathiou E. Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer. Scientific Reports. 6: 35354. PMID 27748439 DOI: 10.1038/srep35354  0.4
2015 Aparicio AM, Shen L, Li Ning Tapia EM, Lu JF, Chen HC, Zhang J, Wu G, Wang X, Troncoso P, Corn P, Thompson TC, Broom B, Baggerly KA, Maity SN, Logothetis C. Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26546618 DOI: 10.1158/1078-0432.CCR-15-1259  0.4
2012 Wan X, Liu J, Lu JF, Tzelepi V, Yang J, Starbuck MW, Diao L, Wang J, Efstathiou E, Vazquez ES, Troncoso P, Maity SN, Navone NM. Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 726-36. PMID 22298898 DOI: 10.1158/1078-0432.CCR-11-2521  0.4
2012 Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, Hoang A, Efstathiou E, Sircar K, Navone NM, Troncoso P, Liang S, Logothetis CJ, Maity SN, Aparicio AM. Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 666-77. PMID 22156612 DOI: 10.1158/1078-0432.CCR-11-1867  0.4
2011 Luo R, Klumpp SA, Finegold MJ, Maity SN. Inactivation of CBF/NF-Y in postnatal liver causes hepatocellular degeneration, lipid deposition, and endoplasmic reticulum stress. Scientific Reports. 1: 136. PMID 22355653 DOI: 10.1038/srep00136  0.4
2011 Li J, Ding Z, Wang Z, Lu JF, Maity SN, Navone NM, Logothetis CJ, Mills GB, Kim J. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention. Plos One. 6: e28840. PMID 22194926 DOI: 10.1371/journal.pone.0028840  0.4
2011 Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Research. 71: 5194-203. PMID 21670081 DOI: 10.1158/0008-5472.CAN-10-4374  0.4
2010 Coustry F, Oh CD, Hattori T, Maity SN, de Crombrugghe B, Yasuda H. The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template. Nucleic Acids Research. 38: 6018-28. PMID 20484372 DOI: 10.1093/nar/gkq417  0.48
2010 Oh CD, Maity SN, Lu JF, Zhang J, Liang S, Coustry F, de Crombrugghe B, Yasuda H. Identification of SOX9 interaction sites in the genome of chondrocytes. Plos One. 5: e10113. PMID 20404928 DOI: 10.1371/journal.pone.0010113  0.48
2008 Luo R, Lu JF, Hu Q, Maity SN. CBF/NF-Y controls endoplasmic reticulum stress induced transcription through recruitment of both ATF6(N) and TBP. Journal of Cellular Biochemistry. 104: 1708-23. PMID 18348279 DOI: 10.1002/jcb.21736  0.96
2006 Hu Q, Lu JF, Luo R, Sen S, Maity SN. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle. Nucleic Acids Research. 34: 6272-85. PMID 17098936 DOI: 10.1093/nar/gkl801  0.96
2003 Bhattacharya A, Deng JM, Zhang Z, Behringer R, de Crombrugghe B, Maity SN. The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation. Cancer Research. 63: 8167-72. PMID 14678971  0.48
2002 Hu Q, Bhattacharya C, Maity SN. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required. The Journal of Biological Chemistry. 277: 37191-200. PMID 12149265 DOI: 10.1074/jbc.M205985200  0.96
2001 Coustry F, Hu Q, de Crombrugghe B, Maity SN. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure. The Journal of Biological Chemistry. 276: 40621-30. PMID 11514576 DOI: 10.1074/jbc.M106918200  0.96
2000 Hu Q, Maity SN. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes. The Journal of Biological Chemistry. 275: 4435-44. PMID 10660616  0.96
Low-probability matches
2018 Zacharias N, Lee J, Ramachandran S, Shanmugavelandy S, McHenry J, Dutta P, Millward S, Gammon S, Efstathiou E, Troncoso P, Frigo DE, Piwnica-Worms D, Logothetis CJ, Maity SN, Titus MA, et al. Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29748904 DOI: 10.1007/s11307-018-1199-6  0.08
2017 Karanika S, Karantanos T, Li L, Wang J, Park S, Yang G, Zuo X, Song JH, Maity SN, Manyam GC, Broom B, Aparicio AM, Gallick GE, Troncoso P, Corn PG, et al. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling. Cell Reports. 18: 1970-1981. PMID 28228262 DOI: 10.1016/j.celrep.2017.01.072  0.08
2014 Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Takahiro H, Dobashi M, Zhang W, Efstathiou E, Maity SN, et al. Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer. Science Signaling. 7: ra47. PMID 24847116 DOI: 10.1126/scisignal.2005070  0.08
2011 Aparicio A, Tzelepi V, Araujo JC, Guo CC, Liang S, Troncoso P, Logothetis CJ, Navone NM, Maity SN. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles. The Prostate. 71: 846-56. PMID 21456067 DOI: 10.1002/pros.21301  0.08
2010 Gorlov IP, Sircar K, Zhao H, Maity SN, Navone NM, Gorlova OY, Troncoso P, Pettaway CA, Byun JY, Logothetis CJ. Prioritizing genes associated with prostate cancer development. Bmc Cancer. 10: 599. PMID 21044312 DOI: 10.1186/1471-2407-10-599  0.08
2018 Soundararajan R, Aparicio AM, Logothetis CJ, Mani SA, Maity SN. Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers. Frontiers in Oncology. 8: 69. PMID 29600194 DOI: 10.3389/fonc.2018.00069  0.04
2015 Varkaris A, Corn PG, Parikh NU, Efstathiou E, Song JH, Lee YC, Aparicio AM, Hoang A, Gaur S, Thorpe L, Maity SN, Bar-Eli M, Czerniak BA, Shao Y, Alauddin M, et al. Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR-2 as Targets for Growth Inhibition of Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26272062 DOI: 10.1158/1078-0432.CCR-15-0235  0.04
2015 Shi Z, Chiang CI, Labhart P, Zhao Y, Yang J, Mistretta TA, Henning SJ, Maity SN, Mori-Akiyama Y. Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells. Nucleic Acids Research. 43: 6257-69. PMID 26040697 DOI: 10.1093/nar/gkv568  0.04
2014 Yamanaka T, Tosaki A, Kurosawa M, Matsumoto G, Koike M, Uchiyama Y, Maity SN, Shimogori T, Hattori N, Nukina N. NF-Y inactivation causes atypical neurodegeneration characterized by ubiquitin and p62 accumulation and endoplasmic reticulum disorganization. Nature Communications. 5: 3354. PMID 24566496 DOI: 10.1038/ncomms4354  0.04
2013 Logothetis CJ, Gallick GE, Maity SN, Kim J, Aparicio A, Efstathiou E, Lin SH. Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer. Cancer Discovery. 3: 849-61. PMID 23811619 DOI: 10.1158/2159-8290.CD-12-0460  0.04
2012 Dayyani F, Parikh NU, Varkaris AS, Song JH, Moorthy S, Chatterji T, Maity SN, Wolfe AR, Carboni JM, Gottardis MM, Logothetis CJ, Gallick GE. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. Plos One. 7: e51189. PMID 23300537 DOI: 10.1371/journal.pone.0051189  0.04
2011 Aparicio A, Logothetis CJ, Maity SN. Understanding the lethal variant of prostate cancer: power of examining extremes. Cancer Discovery. 1: 466-8. PMID 22586648 DOI: 10.1158/2159-8290.CD-11-0259  0.04
2018 Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, Kies MS, Maity SN, Lin SH, El-Naggar AK. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. PMID 30289966 DOI: 10.1002/cncr.31600  0.01
2017 Lin SC, Lee YC, Yu G, Cheng CJ, Zhou X, Chu K, Murshed M, Le NT, Baseler L, Abe JI, Fujiwara K, deCrombrugghe B, Logothetis CJ, Gallick GE, Yu-Lee LY, Maity SN, et al. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Developmental Cell. 41: 467-480.e3. PMID 28586644 DOI: 10.1016/j.devcel.2017.05.005  0.04
2016 Maity SN. NF-Y (CBF) regulation in specific cell types and mouse models. Biochimica Et Biophysica Acta. PMID 27815195 DOI: 10.1016/j.bbagrm.2016.10.014  0.01
2016 Yamanaka T, Tosaki A, Miyazaki H, Kurosawa M, Koike M, Uchiyama Y, Maity SN, Misawa H, Takahashi R, Shimogori T, Hattori N, Nukina N. Differential roles of NF-Y transcription factor in ER chaperone expression and neuronal maintenance in the CNS. Scientific Reports. 6: 34575. PMID 27687130 DOI: 10.1038/srep34575  0.01
2015 Lee YC, Gajdosik MS, Josic D, Clifton JG, Logothetis C, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Molecular & Cellular Proteomics : McP. 14: 471-83. PMID 25527621 DOI: 10.1074/mcp.M114.039909  0.01
2014 Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6570-81. PMID 25316813 DOI: 10.1158/1078-0432.CCR-14-1746  0.01
2004 Chattopadhyay C, Hawke D, Kobayashi R, Maity SN. Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro. Nucleic Acids Research. 32: 3632-41. PMID 15243141 DOI: 10.1093/nar/gkh692  0.01
Hide low-probability matches.